ProSomnus SPAC Presentation Deck
May 2022, 38 slides
  1. ProSomnus
  2. Related Decks
  3. SPAC Presentation Decks
company introduction may | ProSomnus
disclaimer | ProSomnus
disclaimer | ProSomnus
key messages large growing disease with significant limitations of current therapies result in inadequate alleviation and do not offer the remote monitoring data that physicians need to better manage the disease is a pioneer of precision oral appliance therapy oat a new category of devices associated with better outcomes and patient preference proven product effectiveness business model and ability to scale launch of novel continuous patient monitoring platform is expected to transform clinicians ability to better manage the disease with critical real time data proprietary digital manufacturing platform enables clinically meaningful precision therapy advantages and quality for devices | ProSomnus
is changing the way is treated million billion million million adherence than other treatment alternatives to date scalable digital manufacturing platform | ProSomnus
significant disruption of market is set to occur which would you choose a | ProSomnus
initiatives underway to drive potential significant growth north sales force expansion international expansion direct to consumer marketing and clinician education launch of novel continuous patient monitoring device a a | ProSomnus
is highly prevalent and associated with major health consequences sey | ProSomnus
too many people globally continue to suffer from a | ProSomnus
medical insurance reimbursement economics are attractive for all stakeholders cone of eer | ProSomnus
effectiveness of incumbent therapies is limited | ProSomnus
we believe that is the only therapy that meets gold standard for adherence hours cor | ProSomnus
efficacy comparable to for mild and moderate | ProSomnus
in summary delivers outstanding clinical results and a patient preferred experience | ProSomnus
the difference precision personalized sleep medicine therapy us | ProSomnus
proprietary digital manufacturing capabilities enable precision performance advantages us | ProSomnus
next gen device with continuous monitoring poised to change sleep medicine a | ProSomnus
sales marketing to jointly drive growth push to dentists and sleep physicians pull patients to dentists and sleep physicians a intended audiences as | ProSomnus
growing library of evidence indicating performance sleep june sleep science | ProSomnus
medical affairs active studies study objective design status expected next steps other studies | ProSomnus
exceptional management team with deep medical and dental device zephyr | ProSomnus
significant growth potential and attractive financial prospects margin | ProSomnus
transaction summary i pro ownership existing shareholders existing shareholders equity roll cash to balance sheet lenders | ProSomnus
select public inspire butterfly outset revenue multiple revenue | ProSomnus
an opportunity to transform the market a | ProSomnus
appendix | ProSomnus
current treatment options deliver low levels of disease alleviation and are costly | ProSomnus
products outperform the competition | ProSomnus
low adherence limits effectiveness of therapy fisher | ProSomnus
is not like other oats song | ProSomnus
why are patients more adherent with devices legacy oat | ProSomnus
why is more efficacious than legacy oat eas i | ProSomnus
was purposefully designed to be different from other oats | ProSomnus
the product portfolio delivers solutions for a variety of patients | ProSomnus
purposely designed an oral appliance that addresses the limitations of alternative therapies devices feature patented technologies that enable preferred treatment outcomes sleep at titration mechanism degree precision prescription transfer ass biomechanics personalization we biomechanics volume biomechanics lip seal aspect therapy biomechanics true anatomy | ProSomnus
more patient friendly alternatives and marketing have transformed established markets before inspire | ProSomnus
incumbent therapies do not meet continuous oxygen monitoring needs of sleep medicine predictive therapy type adherence position airway i | ProSomnus
non adjusted reconciliation a | ProSomnus
See More
ProSomnus
SPAC Presentation Decks
Medical Devices Decks
Healthcare Decks
Explore Topics
Sleep
Related decks
Alkermes
Investor Conference
January 2024
Nyxoah
IPO
June 2021
Albireo Pharma
Results
October 2022
Alkermes
Results
October 2023
Alkermes
Investor Conference
January 2024
Nyxoah
IPO
June 2021
Albireo Pharma
Results
October 2022
Alkermes
Results
October 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights